Addus HomeCare (NASDAQ:ADUS) Now Covered by Analysts at BMO Capital Markets

Stock analysts at BMO Capital Markets started coverage on shares of Addus HomeCare (NASDAQ:ADUS) in a research note issued to investors on Thursday, Marketbeat reports. The brokerage set a “market perform” rating and a $120.00 price target on the stock. BMO Capital Markets’ target price points to a potential upside of 6.84% from the stock’s current price.

Several other research firms have also recently commented on ADUS. TD Cowen upped their target price on shares of Addus HomeCare from $139.00 to $140.00 and gave the company a “buy” rating in a research note on Wednesday, November 5th. Weiss Ratings reaffirmed a “hold (c+)” rating on shares of Addus HomeCare in a report on Wednesday, October 8th. Stephens restated an “overweight” rating and set a $140.00 price target on shares of Addus HomeCare in a research note on Wednesday, September 3rd. Barclays upped their target price on shares of Addus HomeCare from $111.00 to $117.00 and gave the stock an “underweight” rating in a report on Tuesday, November 4th. Finally, JMP Securities reaffirmed a “market outperform” rating and set a $150.00 price objective on shares of Addus HomeCare in a report on Wednesday, July 16th. One analyst has rated the stock with a Strong Buy rating, eight have given a Buy rating, two have assigned a Hold rating and one has assigned a Sell rating to the stock. According to data from MarketBeat, the stock presently has an average rating of “Moderate Buy” and a consensus target price of $137.11.

Addus HomeCare Stock Down 1.2%

Shares of ADUS stock traded down $1.39 on Thursday, hitting $112.32. The stock had a trading volume of 16,686 shares, compared to its average volume of 181,629. Addus HomeCare has a 52-week low of $88.96 and a 52-week high of $136.72. The firm has a market capitalization of $2.08 billion, a price-to-earnings ratio of 24.79, a P/E/G ratio of 1.87 and a beta of 0.88. The company has a debt-to-equity ratio of 0.17, a quick ratio of 1.74 and a current ratio of 1.74. The stock’s 50 day moving average is $115.25 and its 200-day moving average is $112.98.

Addus HomeCare (NASDAQ:ADUS) last announced its quarterly earnings results on Monday, November 3rd. The company reported $1.56 earnings per share (EPS) for the quarter, topping the consensus estimate of $1.53 by $0.03. The business had revenue of $362.30 million for the quarter, compared to the consensus estimate of $354.48 million. Addus HomeCare had a return on equity of 9.39% and a net margin of 6.51%.The business’s revenue was up 25.0% on a year-over-year basis. During the same quarter last year, the business posted $1.30 EPS. As a group, research analysts expect that Addus HomeCare will post 4.59 earnings per share for the current year.

Insider Activity

In related news, EVP Brian Poff sold 7,739 shares of Addus HomeCare stock in a transaction on Monday, August 25th. The stock was sold at an average price of $116.82, for a total transaction of $904,069.98. Following the sale, the executive vice president directly owned 56,980 shares in the company, valued at approximately $6,656,403.60. This trade represents a 11.96% decrease in their ownership of the stock. The sale was disclosed in a legal filing with the SEC, which can be accessed through this link. Also, Director Veronica Hill-Milbourne sold 1,571 shares of Addus HomeCare stock in a transaction that occurred on Tuesday, August 19th. The shares were sold at an average price of $114.93, for a total transaction of $180,555.03. Following the completion of the transaction, the director owned 5,067 shares of the company’s stock, valued at $582,350.31. This represents a 23.67% decrease in their ownership of the stock. The disclosure for this sale is available in the SEC filing. Insiders sold a total of 34,310 shares of company stock worth $3,958,375 over the last quarter. 4.50% of the stock is currently owned by corporate insiders.

Institutional Inflows and Outflows

Institutional investors have recently bought and sold shares of the company. Tributary Capital Management LLC boosted its stake in Addus HomeCare by 114.1% in the 3rd quarter. Tributary Capital Management LLC now owns 398,122 shares of the company’s stock worth $46,974,000 after purchasing an additional 212,192 shares during the period. Nuveen LLC purchased a new stake in shares of Addus HomeCare in the first quarter valued at $16,155,000. Wellington Management Group LLP boosted its position in shares of Addus HomeCare by 25.8% during the first quarter. Wellington Management Group LLP now owns 471,935 shares of the company’s stock valued at $46,670,000 after buying an additional 96,823 shares during the period. Allianz Asset Management GmbH grew its position in Addus HomeCare by 1,229.4% in the 1st quarter. Allianz Asset Management GmbH now owns 100,898 shares of the company’s stock valued at $9,978,000 after acquiring an additional 93,308 shares during the last quarter. Finally, Leeward Investments LLC MA purchased a new position in Addus HomeCare in the 2nd quarter worth about $9,152,000. Institutional investors own 95.35% of the company’s stock.

About Addus HomeCare

Addus HomeCare Corporation, together with its subsidiaries, provides personal care services to elderly, chronically ill, disabled persons, and individuals who are at risk of hospitalization or institutionalization in the United States. The company operates through three segments: Personal Care, Hospice, and Home Health.